Conditional termination fee payable by the company upon termination of merger agreement.

No definition available.

Name:	agrx_MergerAgreementConditionalTerminationFeePayable
Namespace Prefix:	agrx_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Percentage of outstanding warrants that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.

+ References

No definition available.

+ Details

Name:	agrx_PercentageOfWarrantsToTotalOutstandingWarrantsNumberOfSecuritiesCalled
Namespace Prefix:	agrx_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	instant

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479907/805-20-50-5

+ Details

Name:	us-gaap_BusinessAcquisitionLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination.

+ References

No definition available.

+ Details

Name:	us-gaap_BusinessAcquisitionSharePrice
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:perShareItemType
Balance Type:	na
Period Type:	instant

- Definition

Face amount or stated value per share of common stock.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1

+ Details

Name:	us-gaap_CommonStockParOrStatedValuePerShare
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:perShareItemType
Balance Type:	na
Period Type:	instant

- Details

Name:	us-gaap_BusinessAcquisitionAxis=agrx_InsudPharmaSLAndExeltisProjectIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ClassOfWarrantOrRightAxis=agrx_CommonStockWarrantMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_RangeAxis=srt_MinimumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Merger with Insud Pharma, S.L. (Details) - USD ($) $ / shares in Units, $ in Thousands	Jun. 30, 2024	Jun. 25, 2024	Dec. 31, 2023
Merger with Insud Pharma, S.L.
Par value of common stock (in dollars per share)	$ 0.0001		$ 0.0001
Insud Pharma, S L and Exeltis Project, Inc
Merger with Insud Pharma, S.L.
Par value of common stock (in dollars per share)		$ 0.0001
Merger consideration per share in cash		$ 1.52
Termination fee payable		$ 1,260
Insud Pharma, S L and Exeltis Project, Inc \| Common stock warrants \| Minimum
Merger with Insud Pharma, S.L.
Percentage of warrants and rights outstanding		95.00%